Related Experiment Videos
Prophylactic long-term anticoagulant treatment of hydrocephalic patients with ventriculo-atrial shunts
Insights
Prophylactic anticoagulant therapy in children with spina bifida and ventriculo-atrial shunts did not reduce shunt revisions. However, it significantly decreased distal catheter complications, suggesting a shift in shunt problems to the proximal catheter.
Area of Science:
- Neurosurgery
- Pediatrics
- Cardiovascular Surgery
Background:
- Superior vena cava thrombosis is a significant cause of mortality in patients with ventriculo-atrial shunts.
- Spina bifida is a congenital condition often requiring ventriculo-atrial shunts to manage hydrocephalus.
Purpose of the Study:
- To evaluate the efficacy of prophylactic anticoagulant therapy in preventing shunt complications in spina bifida patients.
- To compare shunt revision rates and catheter-related complications between patients receiving and not receiving anticoagulant therapy.
Main Methods:
- A comparative study involving two groups of spina bifida children with ventriculo-atrial shunts.
- One group received prophylactic anticoagulant therapy; the control group did not.
- Data on shunt revisions and catheter complications were collected over a six-year period.
Main Results:
- No significant difference in the overall number of shunt revisions was observed between the two groups.
- Distal catheter complications were twice as frequent in the group not receiving anticoagulant therapy.
- Proximal catheter revision rates showed minimal difference between the groups.
Conclusions:
- Prophylactic anticoagulant therapy may not reduce the need for shunt revisions in this population.
- Anticoagulant therapy appears to shift shunt complications from the distal to the proximal catheter.
- Proximal catheter obstructions are less dangerous and more amenable to treatment than distal obstructions.
Abstract:
Thrombosis of the superior vena cava is a frequent cause of death among patients with ventriculo-atrial shunts. In this study, one group of spina-bifida children with such shunts was treated with prophylactic anticoagulant therapy and a second group was not. While there was no significant difference between the two groups in the number of shunt revisions required over a six-year period, distal catheter complications were twice as frequent in the group not receiving anticoagulant therapy. There was little difference between the groups in the rate of proximal catheter revisions. It is suggested that the benefit of anticoagulant therapy is in transferring shunt problems from the distal to the proximal catheter, obstruction of which is less dangerous and more easily treated.